Clinicopathologic and prognostic significance of SATB1 in cutaneous malignant melanoma (Q84569900)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21767935%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

title

Clinicopathologic and prognostic significance of SATB1 in cutaneous malignant melanoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21767935%20AND%20SRC:MED&resulttype=core&format=json

neoplastic gene expression regulation

7 February 2020

main subject

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21767935

7 December 2024

6

Satoshi Takeuchi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21767935%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

3

Junna Oba

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21767935

7 December 2024

author name string

Hongxiang Chen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21767935%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Masakazu Takahara

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21767935%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Lining Xie

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21767935%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Takahito Chiba

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21767935%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Yating Tu

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21767935%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Takeshi Nakahara

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21767935%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Hiroshi Uchi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21767935%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Yoichi Moroi

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21767935%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Masutaka Furue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21767935%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21767935

7 December 2024

publication date

23 June 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21767935%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

7 February 2020

https://api.elsevier.com/content/article/PII:S0923181111001812?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.JDERMSCI.2011.06.007

https://api.elsevier.com/content/article/PII:S0923181111001812?httpAccept=text/plain

7 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.JDERMSCI.2011.06.007

Journal of Dermatological Science

7 December 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21767935%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

volume

64

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21767935%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21767935%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

page(s)

39-44

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21767935%20AND%20SRC:MED&resulttype=core&format=json

Treatment of metastatic melanoma: an overview

7 February 2020

cites work

2

1 reference

https://api.crossref.org/works/10.1016/J.JDERMSCI.2011.06.007

Treatment of melanoma metastases confined to the liver and future perspectives

7 December 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.JDERMSCI.2011.06.007

mTOR is activated in the majority of malignant melanomas

7 December 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.JDERMSCI.2011.06.007

Combined inhibition of MAPK and mTOR signaling inhibits growth, induces cell death, and abrogates invasive growth of melanoma cells

7 December 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.JDERMSCI.2011.06.007

7 December 2024

Cancer statistics, 2008

6

1 reference

https://api.crossref.org/works/10.1016/J.JDERMSCI.2011.06.007

The role of chemotherapy in the treatment of patients with brain metastases from solid tumors

7 December 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.JDERMSCI.2011.06.007

Lack of cytoplasmic ERK activation is an independent adverse prognostic factor in primary cutaneous melanoma

7 December 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.JDERMSCI.2011.06.007

Bim expression is reduced in human cutaneous melanomas

7 December 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.JDERMSCI.2011.06.007

The treatment of brain metastases in melanoma patients

7 December 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.JDERMSCI.2011.06.007

The latest diagnostical methods and therapy in melanoma

7 December 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.JDERMSCI.2011.06.007

IGF1 promotes resistance to apoptosis in melanoma cells through an increased expression of BCL2, BCL-X(L), and survivin

7 December 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.JDERMSCI.2011.06.007

STAT3 as a biomarker of progression in atypical nevi of patients with melanoma: dose-response effects of systemic IFNalpha therapy

7 December 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.JDERMSCI.2011.06.007

Phospho-ERK staining is a poor indicator of the mutational status of BRAF and NRAS in human melanoma.

7 December 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.JDERMSCI.2011.06.007

SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis

7 December 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.JDERMSCI.2011.06.007

Global regulator SATB1 recruits beta-catenin and regulates T(H)2 differentiation in Wnt-dependent manner.

7 December 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.JDERMSCI.2011.06.007

Overexpression of SATB1 in laryngeal squamous cell carcinoma.

7 December 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.JDERMSCI.2011.06.007

Overexpression and involvement of special AT-rich sequence binding protein 1 in multidrug resistance in human breast carcinoma cells

7 December 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.JDERMSCI.2011.06.007

The mRNA expression of SATB1 and SATB2 in human breast cancer.

7 December 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.JDERMSCI.2011.06.007

New advances in breast cancer metastasis

7 December 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.JDERMSCI.2011.06.007

Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system

7 December 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.JDERMSCI.2011.06.007

Ulceration and prognosis in cutaneous malignant melanoma

7 December 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.JDERMSCI.2011.06.007

A new path to the cancer epigenome

7 December 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.JDERMSCI.2011.06.007

A tissue-specific MAR/SAR DNA-binding protein with unusual binding site recognition

7 December 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.JDERMSCI.2011.06.007

The fate of the nuclear matrix-associated-region-binding protein SATB1 during apoptosis

7 December 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.JDERMSCI.2011.06.007

A role for SATB1, a nuclear matrix association region-binding protein, in the development of CD8SP thymocytes and peripheral T lymphocytes

7 December 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.JDERMSCI.2011.06.007

SATB1 defines the developmental context for gene silencing by Xist in lymphoma and embryonic cells

7 December 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.JDERMSCI.2011.06.007

The bcl-2 major breakpoint region (mbr) possesses transcriptional regulatory function

7 December 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.JDERMSCI.2011.06.007

SATB1 binds an intronic MAR sequence in human PI3kgamma in vitro

7 December 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.JDERMSCI.2011.06.007

7 December 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21767935%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference